Forte Capital LLC Bristol Myers Squibb CO Transaction History

Forte Capital LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$47.98 - $54.4 $2,878 - $3,264	-60 Reduced 1.49%	3,963 $214,000
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $47,413 - $56,577	-978 Reduced 19.56%	4,023 $206,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $7,236 - $8,091	-125 Reduced 2.44%	5,001 $290,000
Q2 2023 Aug 09, 2023	SELL	$63.71 - $70.74 $34,467 - $38,270	-541 Reduced 9.55%	5,126 $327,000
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $54,099 - $64,061	790 Added 16.2%	5,667 $407,000
Q3 2022 Oct 21, 2022	BUY	$0.13 - $76.84 $73 - $43,491	566 Added 13.13%	4,877 $347,000
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $580 - $639	8 Added 0.19%	4,311 $332,000
Q4 2021 Jan 20, 2022	SELL	$53.63 - $62.52 $71,703 - $83,589	-1,337 Reduced 23.71%	4,303 $268,000
Q3 2021 Oct 27, 2021	BUY	$59.17 - $69.31 $2,189 - $2,564	37 Added 0.66%	5,640 $334,000
Q2 2021 Jul 28, 2021	BUY	$61.91 - $67.42 $11,886 - $12,944	192 Added 3.55%	5,603 $374,000
Q1 2021 Apr 22, 2021	SELL	$59.34 - $66.74 $53,524 - $60,199	-902 Reduced 14.29%	5,411 $342,000
Q4 2020 Jan 19, 2021	SELL	$57.74 - $65.43 $9,469 - $10,730	-164 Reduced 2.53%	6,313 $392,000
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $9,246 - $10,246	-161 Reduced 2.43%	6,477 $391,000
Q2 2020 Jul 09, 2020	BUY	$54.82 - $64.09 $363,895 - $425,429	6,638 New	6,638 $390,000
Q4 2017 Jan 22, 2018	SELL	$59.94 - $65.35 $215,364 - $234,802	-3,593 Closed	0 $0
Q3 2017 Oct 11, 2017	BUY	$55.23 - $63.74 $198,441 - $229,017	3,593	3,593 $229,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Forte Capital LLC , based on Form 13F filings with the SEC.

Stay updated on Forte Capital LLC with notifications on news.